酏剂

• PHASE2ACTIVE_NOT_RECRUITING
  The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery LesionsElixir Medical Corporation · NCT05033964
• ENROLLING_BY_INVITATION
  Patient Satisfaction and Recovery Outcomes Associated With Perioperative ELIXIR MD UseElixir MD Inc · NCT07311889
• NACOMPLETED
  EXCELLA Post-Approval StudyElixir Medical Corporation · NCT02009956
• NACOMPLETED
  The Effect of Adaptogen Elixir on Sleep ImprovementTCI Co., Ltd. · NCT06279312
• NACOMPLETED
  Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I TrialElixir Medical Corporation · NCT02086006
• NACOMPLETED
  Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx TrialElixir Medical Corporation · NCT02086045

via ClinicalTrials.gov